These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 2021972)
21. Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia. Uckun FM; Fauci AS; Chandan-Langlie M; Myers DE; Ambrus JL J Clin Invest; 1989 Nov; 84(5):1595-608. PubMed ID: 2681271 [TBL] [Abstract][Full Text] [Related]
22. The effect of exogenous lymphokines on immunoglobulin production and lymphocyte proliferation in renal transplant patients. Cardella CJ; Weissgarten J; Ng CM; Friedman E Transplantation; 1989 Feb; 47(2):300-4. PubMed ID: 2645717 [TBL] [Abstract][Full Text] [Related]
23. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I. Kehrl JH; Muraguchi A; Fauci AS Eur J Immunol; 1984 Feb; 14(2):115-21. PubMed ID: 6199210 [TBL] [Abstract][Full Text] [Related]
24. The Bb fragment of complement factor B acts as a B cell growth factor. Peters MG; Ambrus JL; Fauci AS; Brown EJ J Exp Med; 1988 Oct; 168(4):1225-35. PubMed ID: 3262708 [TBL] [Abstract][Full Text] [Related]
25. The direct effects of interleukin 1, interleukin 2, interferon-alpha, interferon-gamma, B-cell growth factor, and a B-cell differentiation factor on resting and activated human B cells. Kehrl JH; Muraguchi A; Goldsmith PK; Fauci AS Cell Immunol; 1985 Nov; 96(1):38-48. PubMed ID: 2424621 [TBL] [Abstract][Full Text] [Related]
26. B cell growth-promoting activity of recombinant human interleukin 4. Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225 [TBL] [Abstract][Full Text] [Related]
27. Hyperreactivity of activated B cells to B cell growth factor in patients with systemic lupus erythematosus. Ueda Y; Sakane T; Tsunematsu T J Immunol; 1989 Dec; 143(12):3988-93. PubMed ID: 2592765 [TBL] [Abstract][Full Text] [Related]
28. Human interleukin 7 is a B cell growth factor for activated B cells. Joshi PC; Choi YS Eur J Immunol; 1991 Mar; 21(3):681-6. PubMed ID: 1826263 [TBL] [Abstract][Full Text] [Related]
29. Antigen-independent regulation of cytoplasmic calcium in B cells with a 12-kDa B-cell growth factor and anti-CD19. Ledbetter JA; Rabinovitch PS; June CH; Song CW; Clark EA; Uckun FM Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1897-901. PubMed ID: 2450350 [TBL] [Abstract][Full Text] [Related]
30. Production of B cell growth factor by normal human B cells. Jurgensen CH; Ambrus JL; Fauci AS J Immunol; 1986 Jun; 136(12):4542-7. PubMed ID: 3519772 [TBL] [Abstract][Full Text] [Related]
31. B cell differentiation factor-induced human B cell maturation: stimulation of intracellular calcium release. Huang R; Cioffi J; Kimberly R; Edberg J; Mayer L Cell Immunol; 1995 Sep; 164(2):227-33. PubMed ID: 7656331 [TBL] [Abstract][Full Text] [Related]
32. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody. Suzuki T; Butler JL; Cooper MD J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946 [TBL] [Abstract][Full Text] [Related]
33. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1). Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094 [TBL] [Abstract][Full Text] [Related]
34. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2. Tseng CT; Springgate CF; Piela TH; Choi YS J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160 [TBL] [Abstract][Full Text] [Related]
35. Human B cell growth factor enhances proliferation and glial fibrillary acidic protein gene expression in rat astrocytes. Benveniste EN; Whitaker JN; Gibbs DA; Sparacio SM; Butler JL Int Immunol; 1989; 1(3):219-28. PubMed ID: 2487687 [TBL] [Abstract][Full Text] [Related]
36. Heterogeneity of B-cell growth factor receptor reactivity in healthy donors and in patients with chronic lymphatic leukemia: relationship to B-cell-derived lymphokines. Benjamin D; Bazar LS; Wallace B; Jacobson RJ Cell Immunol; 1986 Dec; 103(2):394-408. PubMed ID: 3100061 [TBL] [Abstract][Full Text] [Related]
37. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells. Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718 [TBL] [Abstract][Full Text] [Related]
38. Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells. Vazquez A; Auffredou MT; Gerard JP; Delfraissy JF; Galanaud P J Immunol; 1987 Oct; 139(7):2344-8. PubMed ID: 3116080 [TBL] [Abstract][Full Text] [Related]
39. A major 50-kDa human B-cell growth factor-II induces both Tac antigen expression and proliferation by several types of lymphocytes. Kawano M; Matsushima K; Masuda A; Oppenheim JJ Cell Immunol; 1988 Feb; 111(2):273-86. PubMed ID: 2827895 [TBL] [Abstract][Full Text] [Related]
40. The apoptosis and proliferation of SAC-activated B cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression. Li L; Krajewski S; Reed JC; Choi YS Cell Immunol; 1997 May; 178(1):33-41. PubMed ID: 9184696 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]